GeneWorx Capital is a technology venture development firm based in Cambridge, MA. The company is distinguished by a team comprised of MIT technologists, former WallStreet VC investors, and Silicon Valley tech entrepreneurs who have collectively contributed to the creation of billions of dollars of shareholder value through their involvement in various tech companies. Established in 2017, GeneWorx Capital is focused on building high-value enterprises from emergent life science companies and innovations. The company is dedicated to accelerating the commercialization and growth of startups, spinouts from labs and large companies, and businesses within large companies. GeneWorx Capital is also involved in securities trading with offerings through Finalis Securities LLC, a separate and unaffiliated entity. The company operates within the biotechnology, life sciences, and pharmaceutical industries.
GeneWorx Capital
Cambridge, United States
2 employees
Biotechnology, Life Sciences +1
General Information
Get notified when GeneWorx Capital moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track GeneWorx Capital
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About GeneWorx Capital
No funding data available for GeneWorx Capital yet.
Get notified when GeneWorx Capital raises fundingGeneWorx Capital Alternatives & Competitors
A boutique M&A and strategy advisory firm with a focus on consumer facing technology and digital med...
Zenn Capital is focused on providing founders and dreamers the opportunity to efficiently scale thei...
Persistent pursuit of prosperity.
FAQ About GeneWorx Capital
Don't just browse. Track.
Signal Tracker monitors GeneWorx Capital and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.